Microsoft Corp (HKSE:04338)
HK$ 1600 0 (0%) Market Cap: 24.09 Til Enterprise Value: 24.09 Til PE Ratio: 35.91 PB Ratio: 12.18 GF Score: 97/100

Microsoft Corp at RBC Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 04:00PM GMT
Release Date Price: HK$500
Randall S. Stanicky
RBC Capital Markets, Research Division - MD of Global Equity Research & Lead Analyst

Okay. Great. Thanks, everybody, for joining us for day -- our day 2 keynote event. I'm Randall Stanicky, a Pharmaceuticals Analyst here at RBC Capital Markets and joined by my colleague Alex Zukin, who covers the software industry as well as Microsoft.

And just to say, I mean, we're both really excited to have our next keynote speaker with us, Dr. Greg Moore. He's the Corporate Vice President of Microsoft Health, responsible for a host of initiatives, from product strategy to product development, research, including AI, machine learning technology for the life sciences. So a lot of responsibility there. He's also Microsoft's senior executive leading the dedicated R&D collaborations with the company's strategic partners. And that's going to be something that we talk about as well.

And just to give a bit of a background here because it's actually quite important. When you look at his interdisciplinary background, I mean, I think it helps explain how complex and, really, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot